Assistant or Associate Professor, Oncology (BMT / IMTX)

Description

Assistant or Associate Professor, Blood and Marrow Transplant (BMT) and Immunotherapy (IMTX) Programs, on the clinical scholar pathway with an approximate 50:50 contribution to clinical service and academic pursuits. 

The Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) are jointly recruiting two (2) full-time faculty members at the Assistant Professor or Associate Professor level without tenure due to funding (WOT), in the Clinical Research Division of the Fred Hutch and the Division of Medical Oncology, Department of Medicine at the UW. The primary appointment will be in the Clinical Research Division of Fred Hutch. Academic appointment at the University of Washington will be commensurate with experience, qualifications, and academic rank. University of Washington assistant professors WOT are eligible for multi-year appointments and associate professors WOT hold indefinite appointments that both align with a 12-month service period (July 1-June 30). Faculty with 12-month service periods are paid for 11 months of service over a 12-month period (July-June), meaning the equivalent of one month is available for paid time off.

The selected individuals for the advertised position are expected to contribute to our mission of delivering outstanding clinical care and developing excellence in clinical research in transplantation and/or immunotherapy. All clinical and translational research experiences and interests will be considered, and expertise and focus in allogeneic and autologous transplantation and cellular immunotherapy is highly desirable. Fred Hutch and University of Washington faculty engage in teaching, research, and service. Teaching responsibilities will involve oversight of advanced practice providers and fellows during inpatient and outpatient rotations, and delivery of informal teaching sessions and formal lectures to providers and the general medical community.

Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.

With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.

At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.

This position is paid directly by Fred Hutchinson Cancer Center (Fred Hutch) and receives no UW compensation.  Please refer to Fred Hutch for information about compensation for this position.

Anticipated Start Date: March 1, 2025

Qualifications

The ideal candidates should have a record of and primary interest in hematopoietic cell transplantation and/or cellular immunotherapy, as well as an active clinical research interest, as demonstrated by peer-reviewed publications, in the application of these treatment modalities to the treatment of human disease.   

 

Applicants must have an MD/DO degree (or foreign equivalent), board certification in Medical Oncology or Hematology (or foreign equivalent) and must be eligible for medical licensure in the state of Washington. In order to be eligible for sponsorship for an H-1B visa, graduates of foreign (non-U.S.) medical schools must show successful completion of all three steps of the U.S. Medical